An Australian stem cell and regenerative medicine company

November 06, 2024

Euroz Hartleys intitiates coverage: "Unlimited Cells, Unlimited Possibilities"

View Report

August 06, 2024

MST Access update: "Clinical Trials On Track"

View Report

May 10, 2024

MST Access update: "3Q24: progressing on all fronts"

View Report

February 28, 2024

MST Access update: "Phase 1 DFU trial: initial data very promising; recruitment continues"

View Report

View the MST Access Research Update on Cynata Therapeutics

December 01, 2023

MST Access re-initiates coverage: "Harnessing Stem Cell Potential"

View Report

View the MST Access Research Report on Cynata Therapeutics